If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
123.00    2.50 (2.07%)
Bid:
118.00
Ask:
120.00
Spread: 2.00 (1.695%)
Market Cap: £96.52m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Manufacturing rationalisation

1 Apr 2009 07:00

RNS Number : 8292P
Xaar PLC
01 April 2009
 



FOR IMMEDIATE RELEASE

1 April 2009

Xaar plc

RATIONALISATION OF MANUFACTURING FACILITIES

100 NEW HIGH TECHNOLOGY JOBS TO BE CREATED IN THE UK

Xaar plc ("Xaar" or "the Company"), the inkjet printing technology group headquartered in Cambridge, can confirm that it will now proceed with the rationalisation of its manufacturing facilities.

As part of the proposed rationalisation, approximately 100 new jobs will be created at the Company's 'state of the art' Huntingdon plant over the period of the transfer.

Further to the disclosure of the proposal in the final results announcement on 23 March 2009, the period of consultation with the representatives of the workforce of approximately 130 at the Company's Swedish manufacturing facility in Järfälla, near Stockholm, has now ended. Accordingly, Xaar's Board has decided to proceed with rationalising its production of printheads by transferring manufacturing from the plant in Sweden to its facility in Huntingdon, near Cambridge, and the eventual closure of the Järfälla facility. The process is expected to take about two years to complete in a phased transfer to ensure minimal disruption to the business and continued availability of finished product.

As stated previously, the transfer is expected to achieve:

a substantial reduction in manufacturing costs;
a reduction in management overhead;
better use of production capacity;
improved operational efficiency; and 
the elimination of exchange rate exposure between Sterling and the Swedish Krona.

Ian Dinwoodie, Xaar's Chief Executive, commented:

"We plan to fund the relocation of our Swedish manufacturing activities to Huntingdon with a mix of cash generated from our operations and some external equipment finance. We aim to preserve our cash balances and strong balance sheet."

Ends

 

CONTACTS

Xaar plc:
01223-423663
Ian Dinwoodie, Chief Executive
www.xaar.com
Andrew Taylor, Finance Director
 
 
 
Bankside Consultants:
 
Steve Liebmann or Simon Bloomfield
020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMGGFFFMLGLZM
Date   Source Headline
13th Mar 200810:21 amRNSDividend Payment Date
13th Mar 20087:01 amRNSFinal Results
19th Feb 20087:00 amRNSNotice of Final Results
8th Feb 20087:00 amRNSCustomer product launch
30th Jan 20087:00 amRNSDirectorate Change
29th Jan 20087:01 amRNSControl change for partner
10th Jan 20087:01 amRNSYear end trading update
9th Jan 20087:00 amRNSHolding(s) in Company
4th Jan 20083:59 pmRNSTotal Voting Rights
2nd Jan 20089:53 amRNSHolding(s) in Company
11th Dec 200712:25 pmRNSHolding(s) in Company
6th Dec 20075:17 pmRNSTotal Voting Rights
30th Nov 200710:26 amRNSHolding(s) in Company
30th Nov 20077:00 amRNSHolding(s) in Company
27th Nov 200710:12 amRNSHolding(s) in Company
31st Oct 20078:30 amRNSHolding(s) in Company
17th Oct 20076:36 pmRNSHolding(s) in Company
15th Oct 20077:00 amRNSAppointment of Director
5th Oct 20075:46 pmRNSDirector/PDMR Shareholding
12th Sep 20077:01 amRNSInterim Results
11th Sep 20077:03 amRNSNew customer product launches
4th Sep 20075:39 pmRNSTotal Voting Rights
3rd Sep 20077:02 amRNSNotice of Interim Results
21st Aug 20075:29 pmRNSHolding(s) in Company
17th Aug 20076:00 pmRNSHolding(s) in Company
17th Aug 20075:40 pmRNSHolding(s) in Company
6th Aug 20077:00 amRNSDirector/PDMR Shareholding
2nd Aug 20074:30 pmRNSTotal Voting Rights
17th Jul 20077:00 amRNSAppointment of R&D Director
13th Jul 200711:05 amRNSHolding(s) in Company
11th Jul 20077:00 amRNSTotal Voting Rights
11th Jul 20077:00 amRNSDirector/PDMR Shareholding
10th Jul 20077:00 amRNSPeriod End Trading Statement
9th Jul 20075:45 pmBUSDutton Associates Announces Investment Opinion: Xaar Plc Rated Buy in Update Report by Dutton Associates
4th Jun 200710:51 amRNSHolding(s) in Company
24th May 20076:11 pmRNSDirector/PDMR Shareholding
24th May 20071:10 pmRNSHolding(s) in Company
23rd May 20077:00 amRNSFacility visit
16th May 20077:01 amRNSAppointment of Chairman
14th May 20077:00 amRNSDirector/PDMR Shareholding
10th May 20076:05 pmRNSDirector/PDMR Shareholding
9th May 20076:19 pmRNSDirector/PDMR Shareholding
1st May 20076:24 pmRNSDirector/PDMR Shareholding
1st May 200711:37 amRNSHolding(s) in Company
24th Apr 200710:20 amRNSDirector/PDMR Shareholding
23rd Apr 200712:56 pmRNSResult of AGM
23rd Apr 20077:01 amRNSAGM Trading Update
13th Apr 20075:00 pmBUSDutton Associates Announces Investment Opinion: Xaar plc Buy Rating Maintained In Update Coverage By Dutton Associates
11th Apr 200711:55 amRNSAnnual Information Update
29th Mar 20071:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.